Genomic Summit 2022 has announced its official schedule

An announcement

The genomics occasion, Genomic Summit, has launched its full schedule for the 2022 version, which can happen on August 24 and 25.

Promoted by Dasa Genomic, the occasion goals to unfold data and showcase new improvements and new companies by docs and well being professionals.

For this motive, it should convey collectively famend specialists from nationwide and worldwide establishments, in free on-line programs, with simultaneous translation into Portuguese, English and Spanish.

“Dissemination of information is essential”, says Gustavo Riedel, enterprise director in genomics and scientific analysis at Dasa.

An announcement

The director factors out that for this reason Dasa Genomics invests in an occasion that focuses on the artwork of genomics.

“In this manner, we share what’s fashionable and up-to-date available in the market of precision medication in Brazil and Latin America, to contribute extra to customized medication. It is the way forward for medication that already exists “, he provides.

The Genomic Conference 2022 can have 32 lectures. They can be divided into two days, with 4 rooms at a time per day.

Each room can have a Dasa Genomic part:

– Human replica and fetal medication,

– Oncology and oncogenetics,

– Onco-hematology,

– Cardiology,

– Pharmacogenomics, uncommon ailments and the brand new entrance of ophthalmology, launched in June this 12 months.

The grasp class can be taught by the North American PhD in genetics Dr. Noura S Abul-Husn, who’s an Assistant Professor of Medicine and Genetics, founding director of the Division of Genomic Medicine within the Department of Medicine, and Clinical Director of the Institute of Genomic Health on the Icahn School of Medicine at Mount Sinai, New York. .

The subject can be “Genomic Medicine in folks with genetic variety and admixture”, which can give an summary of the advantages of genetic mapping.

Registrations could be made at:

See the complete schedule:

August 24:


3 pm – The opening of the occasion

3:05 pm – The opening of the principle level

15:10- Magna – Genomic medication in folks with completely different and blended genetics

Noura S Abul-Husn, MD, PhD – Assistant Professor of Medicine and Genetics

Ophthalmology Group:

4 pm – Anterior phase genetics. Corneal, Lens and Glaucoma Diseases

Eduardo Silva – Director of CRI-OftaPed, Dona Estefânia Hospital and Centro Hospitalar Universitário Lisboa Central, Portugal

17h – retinal dystrophies

René Moya – surgeon and specialist in ocular genetics, Adjunct Professor of Ophthalmology on the University of Chile and Director of the Department of Retina and Ocular Genetics on the Hospital del Salvador in Santiago, Chile

18h – retinoblastoma

Luiz Fernando Teixeira – Doctor of Ophthalmology on the Department of Ophthalmology on the Federal University of São Paulo

19h – The significance of genetic testing in ophthalmology and gene remedy

Juliana Sallum – Head of Ophthalmology at Dasa, PhD in Ophthalmology from the Federal University of São Paulo (Unifesp) and Johns Hopkins University, within the United States, has experience in Clinical Genetics from the Brazilian Society of Clinical Genetics (SBGC).

Associate professor and head of the Ocular Genetics Section of the Department of Ophthalmology at Unifesp.

Cardiology Group:

4 pm – A brand new worldwide consensus on genetic testing in heart problems. What has modified?

Luciana Sacilotto – Doctor at Genetic Arrhythmias Outpatient Clinic at InCor HC FMUSP, Doctor of Science at USP and Specialist in Clinical Arrhythmia at SOBRAC

17h – The threat of residual lipid. How to strategy?

Dr. Eduardo Gomes Lima – Doctor in Cardiology from the Faculty of Medicine of the University of São Paulo, Prof. Assistant on the USP School of Medicine, Assistant Physician on the Atherosclerosis Clinical Unit on the Heart Institute of the Hospital das Clínicas on the USP School of Medicine and Teaching and Research Coordinator on the Hospital Nove de Julho

18h – Sudden demise throughout train. What is vital to know?

Fabricio Braga – Master in Cardiology from UFRJ, Medical Director of the Human Performance Laboratory, Chief Medical Officer of the Brazilian Triathlon Confederation and member of the Safety Committee of IRONMAN Brazil

19h – Childhood cardiomyopathies: Updates to the Charisma Registry

Aurea Grippa – PhD and Master scholar in Cardiovascular Sciences at UFF, answerable for Pediatric and Fetal Cardiology at CHN-DASA, Pediatric and fetal heart specialist at Instituto Nacional de Cardiologia – INC, full member of the Brazilian Societies of Cardiology and Pediatrics

Oncogenetics Group:

4 pm – Cancer Risk and Mortality in Lynch Syndrome

Mev Dominguez-Valentin – Scientist on the Institute for Cancer Research at Oslo University Hospital (Norway), Director of the Scientific Board of the European Hereditary Tumor Group (EHTG) and member of the Scientific Board of the Latin American Hereditary Tumor Group (LA-GETH).

17h – Integration of Functional Data for Different Groups in BRCA1

Álvaro Monteiro – PhD, senior member of the Cancer Epidemiology Department on the Moffitt Cancer Center in Florida, USA.

18h – Prostate polygenic threat

Maria Aparecida Koike – Assistant Professor on the Department of Radiology and Oncology on the USP School of Medicine and Coordinator of the Oncogenomics group on the Center for Translational Investigation in Oncology of the Cancer Institute of the State of São Paulo.

19h – Unexpected findings in most cancers stem cell testing

Jeffrey Weitzel – MD. PhD in Oncogenetics, Vice President of Medical Affairs for Hereditary Cancer at Natera and Honorary Professor of Oncology on the Latin American School of Oncology.

Human Reproduction Group:

4 pm – Are there genetic testing facilities that display screen for polar physique aneuploidies?

Robert Fischer – Resident in Obstetrics and Gynecology on the University Hospital Münster, Germany, and University of Nottingham, UK, member of the American Society for Reproductive Medicine (ASRM), founding member of the European Society for Human Reproduction (ESHRE) and member of the scientific committee of EXCEMED (previously Serono Symposia International Foundation).

17h – Bioethical implications in genomics and genetic modification

Dr. Michel Satya Naslavsky – PhD in genetics from USP and professor on the Department of Genetics and Evolutionary Biology on the Institute of Biosciences at USP and Researcher on the Center for Research on Human Genome and Stem Cells at USP

18h – Endometrial reception

Luis Alcantaras – Biologist specializing in biology and bioinformatics. PHD from the University of Alicante, Spain, and co-founder of Bioarray.

19h – Timelapse and AI in embryonic evaluation: How to interpret the outcomes and enhance the probabilities of being pregnant.

Edson Borges – Co-ordinator of post-graduate research in assisted replica on the Sapientiae Institute and Scientific Director of the Fertility Medical Group

August twenty fifth

Oncology Group:

4 pm – most cancers immunology

Jerome Galon – Deputy Director of the Department of Basic and Clinical Oncology (DOBC), Coordinator of Masters in Pharmacology, Director of Research First Class – Director of the Laboratory for Integrative Cancer Immunology (INSERM), France

17h – The way forward for molecular testing in Oncology

Svetlana Nikic – Deputy Director, Department of Basic and Clinical Oncology (DOBC), Coordinator of the Master of Pharmacology, Senior Manager of Market Development in Oncology at Illumina.

18h – Targeted methylation within the central nervous system

David Capper – Professor of Molecular Neuropathology on the Institute of Neuropathology at Charité University Hospital in Berlin, Germany

19h – The impression of residual molecular analysis based mostly on circulating tumor DNA within the course and construction of scientific research of stable tumors.

Pashtoon M. Kasi – Director of Colon Cancer Research, Liquid Biopsy Research at Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine Englander Institute of Precision Medicine, New York, USA

Pharmacogenomics class:

4 pm – Economic and Clinical Outcomes of the Precision Health Program

Jeffrey A. Shaman – PhD, MS, Chief Science Officer at Coriell Life Sciences, Philadelphia, USA

17h – Clinical software of pharmacogenomics in cardiology

Luis A. Quiñones – Biochemist, Ph.D. in Biomedical Sciences, Deputy Director of the Department of Basic and Clinical Oncology (DOBC) and Coordinator of Masters in Pharmacology on the Faculty of Medicine of the University of Chile. President of the Latin American Society of Pharmacogenomics and Personalized Medicine

18h – Clinical software of pharmacogenomics in oncology

Luis A. Quiñones – – Biochemist, Ph.D. in Biomedical Sciences, Deputy Director of the Department of Basic and Clinical Oncology (DOBC) and Coordinator of Masters in Pharmacology on the Faculty of Medicine of the University of Chile. President of the Latin American Society of Pharmacogenomics and Personalized Medicine

19h – Pharmacogenomics and Artificial Intelligence for power illness administration in main care

Dr. Ryan Nelson – Physician Director of Precision Medicine and Adjunct Professor of Medicine on the University of Utah within the United States.

A bunch of uncommon ailments:

4 pm – Navarra’s Comprehensive Personalized Medicine Strategy

Juan Cruz Cigudosa – Councilor of the University, Innovation and Digital Transformation within the Government of Navarra, Spain.

17h – lengthy studying

Nara Sobreira – Associate Professor within the Department of Genetic Medicine at Johns Hopkins Hospital in Baltimore, USA, and Dasa Genomics Consultant

18h – An outreach program in Chile for sufferers with uncommon ailments

Juan Francisco Cabello – Director of the Pediatric Neurology Fellowship Program on the University of Valparaíso, Chile. Director of Inborn Errors of Metabolism Laboratory, Visiting Scientist in Neurology at Children’s Hospital Boston, USA.

19h – Achondroplasia: new remedy choices and challenges to beat

Dr. Melita Irving – Genetics Specialist at Guy’s and St Thomas Hospitals, London, UK, the place she specializes within the space of ​​skeletal dysplasias, the place she is an internationally acknowledged specialist. He was chairman of the Human Genetics Section of the Royal Society of Medicine.

Oncohematology Group

4 pm – LLA Ph as

Belinda Simoes – FMRP-USP Scholarship, PhD and FMRP-USP, Post-Doctor Ludwig Maximiliam University Munich Germany and Professor at FMRP-USP till 2019.

17h – Laboratory analysis of myeloma within the period of latest medication

Roberto Magalhães – Hematologist MD, PhD, UFRJ. Technical Responsible and Coordinator of Hematology at Dasa Oncology and Hospital Complex of Niterói (CHN), in Rio de Janeiro and Coordinator of Hematology and Bone Marrow Transplantation Group of Niterói (GHTN)

18h – Cancer and the Microbiome

Daniel Tabak – Associate Hematologist and Oncologist of Dasa Oncologia,

Fellowship in Hematology-Oncology at Washington University in St.Louis, USA, former Director of the Bone Marrow Transplant Center (INCA), Medical Director of the Cancer Treatment Center (CENTRON) and Titular Member of the National Academy of Medicine.

19h – Future views on the administration of CML in South America

Carolina Pavslobisky – Head Hematologist of the Research Department at Fundaleu (Fundación para Combatir la Leukemia), in Buenos Aires, Argentina

Leave a Comment

Your email address will not be published.